Wed, October 13, 2021
Tue, October 12, 2021
Mon, October 11, 2021

Matthew Harrison Maintained (ALVR) at Buy with Increased Target to $48 on, Oct 12th, 2021

Matthew Harrison of Morgan Stanley, Maintained "AlloVir, Inc." (ALVR) at Buy with Increased Target from $47 to $48 on, Oct 12th, 2021.

Matthew, nor any peers, have made any analyst calls on ALVR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30